Consolidated Statements of Operations (Parenthetical) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|
| Total equity-based compensation expense | $ 127,896 | $ 103,201 | $ 104,447 |
| Cost of revenue | |||
| Total equity-based compensation expense | 16,445 | 13,634 | 12,215 |
| Research and development | |||
| Total equity-based compensation expense | 33,835 | 36,093 | 24,739 |
| Sales and marketing | |||
| Total equity-based compensation expense | 37,369 | 15,304 | 15,843 |
| General and administrative | |||
| Total equity-based compensation expense | $ 40,247 | $ 38,170 | $ 51,650 |